By Covid-19 more likely to cause blood clot than AstraZeneca jab, research suggests
New research suggests that a rare type of blood clot is around eight times more likely to occur after contracting Covid-19 than after being administered the AstraZeneca jab.
Researchers examined electronic health records to estimate the probability of suffering with cerebral venous thrombosis (CVT) in the two weeks after being diagnosed with Covid-19, and getting the AstraZeneca jab against the virus.
The report concluded that the risk of suffering with a CVT was about eight times greater after contracting the virus than after receiving the vaccine.
It found that the incidence of CVT after a diagnosis of Covid-19 was 39 per one million people.
The research was conducted after an Oxford scientist said the potential risks of developing blood clots from a Covid-19 vaccination are “pretty trivial” when compared with those posed by contracting the virus.
Professor Sir John Bell, Oxford University’s Regius Professor of Medicine, told Sky News: “If you don’t get a vaccine you’re going to get Covid, and if you get Covid you’ll have a very, very much higher risk of getting a bad clotting problem.
“The best way, if you want to have a bad clotting problem, is to get Covid.
“So, the clotting problems of the vaccine are pretty trivial compared to the real risks of getting clotting problems if you get Covid,” he said.
Contact Gi National
Email us: news@gi-media.co.uk
